Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q4 2014 (← Previous) (Next →)
Filing Date: Feb 17, 2015
Total Value: $649M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | RECEPTOS INC | 641,800 | $78.63M | 12.1% | $43.18 | — | COM | 756207106 |
| PBYI | PUMA BIOTECHNOLOGY INC | 220,000 | $41.64M | 6.4% | $146.25 | +51.7% | COM | 74587V107 |
| — | CELGENE CORP | 300,000 | $33.56M | 5.2% | $111.86 | — | COM | 151020104 |
| — | OVASCIENCE INC | 747,000 | $33.03M | 5.1% | $25.13 | — | COM | 69014Q101 |
| ALKS | ALKERMES PLC | 450,000 | $26.35M | 4.1% | $50.19 | +1.5% | SHS | G01767105 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1,000,000 | $22.34M | 3.4% | $15.30 | +23.9% | COM | 64125C109 |
| — | DYAX CORP | 1,500,000 | $21.09M | 3.3% | $7.54 | — | COM | 26746E103 |
| ARDX | ARDELYX INC | 1,053,500 | $19.9M | 3.1% | $19.95 | +16.1% | COM | 039697107 |
| — | QUOTIENT LTD | 1,100,000 | $19.8M | 3.1% | $13.62 | — | SHS | G73268107 |
| — | REGULUS THERAPEUTICS INC | 1,100,000 | $17.64M | 2.7% | $14.62 | — | COM | 75915K101 |
| SRNE | SORRENTO THERAPEUTICS INC | 1,750,000 | $17.62M | 2.7% | $7.89 | -35.8% | COM NEW | 83587F202 |
| — | PORTOLA PHARMACEUTICALS INC | 600,000 | $16.99M | 2.6% | $27.49 | — | COM | 737010108 |
| — | CHIMERIX INC | 400,000 | $16.1M | 2.5% | $27.07 | — | COM | 16934W106 |
| BMY | BRISTOL MYERS SQUIBB CO | 250,000 | $14.76M | 2.3% | $36.09 | +7.8% | COM | 110122108 |
| — | KITE PHARMA INC | 255,000 | $14.71M | 2.3% | $46.23 | — | COM | 49803L109 |
| OMER | OMEROS CORP | 582,300 | $14.43M | 2.2% | $12.81 | +42.3% | COM | 682143102 |
| — | KARYOPHARM THERAPEUTICS INC | 385,000 | $14.41M | 2.2% | $33.09 | — | COM | 48576U106 |
| — | KERYX BIOPHARMACEUTICALS | 1,000,000 | $14.15M | 2.2% | $13.75 | — | COM | 492515101 |
| — | TESARO INC | 300,000 | $11.16M | 1.7% | $28.24 | — | COM | 881569107 |
| DXCM | DEXCOM INC | 200,000 | $11.01M | 1.7% | $7.91 | +54.7% | COM | 252131107 |
| — | ACCELERON PHARMA INC | 250,000 | $9.74M | 1.5% | $32.10 | — | COM | 00434H108 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 800,000 | $9.728M | 1.5% | $9.67 | +14.2% | COM | 09058V103 |
| — | SYNAGEVA BIOPHARMA CORP | 100,000 | $9.279M | 1.4% | $68.78 | — | COM | 87159A103 |
| — | NOVAVAX INC | 1,500,000 | $8.895M | 1.4% | $4.95 | — | COM | 670002104 |
| SGMO | SANGAMO BIOSCIENCES INC | 500,000 | $7.605M | 1.2% | $17.13 | -29.1% | COM | 800677106 |
| — | ALDER BIOPHARMACEUTICALS INC | 250,000 | $7.273M | 1.1% | $23.68 | — | COM | 014339105 |
| HRTX | HERON THERAPEUTICS INC | 700,000 | $7.042M | 1.1% | $11.95 | -31.7% | COM | 427746102 |
| — | NEKTAR THERAPEUTICS | 450,000 | $6.975M | 1.1% | $12.07 | — | COM | 640268108 |
| — | ACELRX PHARMACEUTICALS INC | 1,000,000 | $6.73M | 1.0% | $9.56 | — | COM | 00444T100 |
| — | ADVAXIS INC | 839,500 | $6.724M | 1.0% | $6.07 | — | COM NEW | 007624208 |
| — | APTOSE BIOSCIENCES INC | 1,083,333 | $6.404M | 1.0% | $5.91 | — | COM NEW | 03835T200 |
| EGRX | EAGLE PHARMACEUTICALS INC | 400,000 | $6.2M | 1.0% | $13.58 | -5.9% | COM | 269796108 |
| — | CHINA BIOLOGIC PRODS INC | 90,000 | $6.051M | 0.9% | $44.47 | — | COM | 16938C106 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 120,000 | $5.266M | 0.8% | $46.32 | -1.1% | COM | 90400D108 |
| — | AUSPEX PHARMACEUTICALS INC | 100,000 | $5.248M | 0.8% | $30.76 | — | COM | 05211J102 |
| — | ARRAY BIOPHARMA INC | 1,000,000 | $4.73M | 0.7% | $5.01 | — | COM | 04269X105 |
| — | VERSARTIS INC | 200,000 | $4.49M | 0.7% | $28.04 | — | COM | 92529L102 |
| — | IMMUNE DESIGN CORP | 140,000 | $4.309M | 0.7% | $17.66 | — | COM | 45252L103 |
| — | NANOSTRING TECHNOLOGIES INC | 300,000 | $4.179M | 0.6% | $20.65 | — | COM | 63009R109 |
| — | ROCKWELL MED INC | 400,000 | $4.112M | 0.6% | $12.66 | — | COM | 774374102 |
| — | BRISTOL MYERS SQUIBB CO | 5,000 | $3.7M | 0.6% | $197.00 | — | CALL | 110122908 |
| CHRS | COHERUS BIOSCIENCES INC | 222,200 | $3.626M | 0.6% | $14.11 | 0.0% | COM | 19249H103 |
| — | DERMIRA INC | 200,000 | $3.622M | 0.6% | $18.11 | — | COM | 24983L104 |
| — | AVALANCHE BIOTECHNOLOGIES IN | 65,000 | $3.51M | 0.5% | $34.18 | — | COM | 05337G107 |
| — | LIPOCINE INC NEW | 666,666 | $3.507M | 0.5% | $5.26 | — | COM | 05360X104 |
| — | GLYCOMIMETICS INC | 472,300 | $3.401M | 0.5% | $16.33 | — | COM | 38000Q102 |
| — | DICERNA PHARMACEUTICALS INC | 200,000 | $3.294M | 0.5% | $16.47 | — | COM | 253031108 |
| — | AGENUS INC | 800,000 | $3.176M | 0.5% | $3.32 | — | COM NEW | 00847G705 |
| — | FORWARD PHARMA A/S-ADR | 150,000 | $3.125M | 0.5% | $20.83 | — | SPONSORED ADR | 34986J105 |
| — | CERULEAN PHARMA INC | 450,000 | $2.799M | 0.4% | $5.80 | — | COM | 15708Q105 |
| — | GENVEC INC | 1,329,300 | $2.765M | 0.4% | $2.65 | — | COM NEW | 37246C307 |
| — | KINDRED BIOSCIENCES INC | 350,000 | $2.608M | 0.4% | $11.93 | — | COM | 494577109 |
| — | AQUINOX PHARMACEUTICALS INC | 300,000 | $2.25M | 0.3% | $12.15 | — | COM | 03842B101 |
| — | RECRO PHARMA INC | 700,000 | $2.002M | 0.3% | $6.07 | — | COM | 75629F109 |
| — | CELLECTAR BIOSCIENCES INC | 530,000 | $1.638M | 0.3% | $2.22 | — | COM NEW | 15117F203 |
| — | CELSUS THERAPEUTICS PLC | 300,000 | $1.44M | 0.2% | $5.99 | — | SPONSORED ADR NE | 15119A202 |
| — | BELLICUM PHARMACEUTICALS INC | 60,000 | $1.382M | 0.2% | $23.03 | — | COM | 079481107 |
| AKBA | AKEBIA THERAPEUTICS INC | 118,000 | $1.374M | 0.2% | $24.08 | -40.4% | COM | 00972D105 |
| — | APPLIED GENETIC TECHNOL CORP | 60,600 | $1.274M | 0.2% | $23.10 | — | COM | 03820J100 |
| GALT | GALECTIN THERAPEUTICS INC | 312,000 | $1.083M | 0.2% | $13.23 | -66.6% | COM NEW | 363225202 |
| — | MINERVA NEUROSCIENCES INC | 175,000 | $1.054M | 0.2% | $6.05 | — | COM | 603380106 |
| — | SCYNEXIS INC | 100,000 | $998K | 0.2% | $8.02 | — | COM | 811292101 |
| VCYT | VERACYTE INC | 100,200 | $968K | 0.1% | $7.80 | 0.0% | COM | 92337F107 |
| — | AGILE THERAPEUTICS INC | 150,000 | $921K | 0.1% | $8.72 | — | COM | 00847L100 |
| — | CURIS INC | 600,000 | $900K | 0.1% | $1.86 | — | COM | 231269101 |
| PTCT | PTC THERAPEUTICS INC | 10,000 | $518K | 0.1% | $26.39 | +66.8% | COM | 69366J200 |
| — | EPIRUS BIOPHARAMCEUTICALS IN | 75,000 | $425K | 0.1% | $5.67 | — | COM | 29428P107 |
| — | CELLECTAR BIOSCIENCES INC | 530,000 | $424K | 0.1% | $0.60 | — | *W EXP 08/19/201 | 15117F112 |
| — | NEVRO CORP | 10,000 | $387K | 0.1% | $38.70 | — | COM | 64157F103 |
| — | SAGE THERAPEUTICS INC | 1,000 | $37,000 | 0.0% | $31.50 | — | COM | 78667J108 |